Exemestane: beside an established treatment under test
33 studies: an approved drug, surgery or radiation is what the study tests. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has SpreadCompletedNCT03659136Phase 2Results postedReport a problem
- A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase InhibitorCompletedNCT03312738Phase 2Results postedReport a problem
- Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerCompletedNCT03176238Phase 3Results postedReport a problem
- Palbociclib With Everolimus + Exemestane In BCCompletedNCT02871791Phase 1/2Results postedReport a problem
- Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast CancerCompletedNCT02258451Phase 2Results postedReport a problem
- BI 836845 in Estrogen Receptor Positive Metastatic Breast CancerCompletedNCT02123823Phase 1Results postedReport a problem
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticActive, not recruitingNCT02115282Phase 3Results postedReport a problem
- Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerCompletedNCT02007512Phase 2Results postedReport a problem
- An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker AnalysisCompletedNCT01743560Phase 4Results postedReport a problem
- Exemestane-RAD001-MetforminTerminatedNCT01627067Phase 2Results postedReport a problem
- A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)CompletedNCT01605396Phase 2Results postedReport a problem
- A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyCompletedNCT01381874Phase 2Results postedReport a problem
- Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast CancerCompletedNCT01151046Phase 2Results postedReport a problem
- Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or AnastrozoleCompletedNCT00863655Phase 3Results postedReport a problem
- Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast CancerTerminatedNCT00793546Phase 2Results postedReport a problem
- Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast CancerCompletedNCT00767520Phase 2Results postedReport a problem
- Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast CancerCompletedNCT00676663Phase 2Results postedReport a problem
- Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast CancerTerminatedNCT00372996Phase 2Results postedReport a problem
- Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On TamoxifenCompletedNCT00038103Phase 2Results postedReport a problem
- Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast CancerStatus unknownNCT03538171Phase 3Report a problem
- Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast CancerCompletedNCT03291886Phase 2Report a problem
- PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast CancerStatus unknownNCT02917005Phase 2Report a problem
- Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast CancerCompletedNCT02676986Phase 2Report a problem
- Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast CancerCompletedNCT02482753Phase 3Report a problem
- Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast CancerWithdrawnNCT01658176Phase 2Report a problem
- 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT01626222Phase 3Report a problem
- Study of Aspirin and Exemestane as Adjuvant Treatment in Breast CancerStatus unknownNCT01431053Phase 2Report a problem
- RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerTerminatedNCT01149356Phase 1Report a problem
- The Impact of Obesity and Obesity Treatments on Breast CancerCompletedNCT00933309Phase 1Report a problem
- Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00931450Phase 1/2Report a problem
- Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast CancerTerminatedNCT00674557Phase 2Report a problem
- Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast CancerWithdrawnNCT00615524Phase 2Report a problem
- Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast CancerCompletedNCT00525096Phase 3Report a problem